Emergency/Compassionate Use - Membranous VSD Occluder

Expanded access is no longer available for this treatment.
Sponsor:
Information provided by (Responsible Party):
St. Jude Medical
ClinicalTrials.gov Identifier:
NCT00583505
First received: December 20, 2007
Last updated: October 21, 2015
Last verified: October 2015
  Purpose
Emergency/Compassionate use of the AMPLATZER Membranous VSD Occluder

Condition Intervention
Membranous
Ventricular
Septal
Defects
VSD
Device: Device closure with the AMPLATZER Membranous VSD Occluder

Study Type: Expanded Access     What is Expanded Access?

Further study details as provided by St. Jude Medical:

Intervention Details:
    Device: Device closure with the AMPLATZER Membranous VSD Occluder
    Device closure with the AMPLATZER Membranous VSD Occluder
  Eligibility

Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Emergency/compassionate use for patients not meeting the inclusion critera for the AMPLATZER Membranous VSD clinical trial
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

No publications provided

Responsible Party: St. Jude Medical
ClinicalTrials.gov Identifier: NCT00583505     History of Changes
Other Study ID Numbers: AGA-008 E/C  G020202 
Study First Received: December 20, 2007
Last Updated: October 21, 2015
Health Authority: United States: Food and Drug Administration

Keywords provided by St. Jude Medical:
membranous
ventricular
septal
defects
VSD

ClinicalTrials.gov processed this record on February 11, 2016